A potential new marker for immunotherapy response could help guide treatment decisions.
All in National Cancer Institute
A potential new marker for immunotherapy response could help guide treatment decisions.
Elusive tumor-targeting T cells share a telltale gene activity signature.
The architectural details of a notorious cancer-promoting protein offer clues about how to keep it safely switched off.
Recurrence of breast cancer metastases in the brain was low among women who received an experimental drug combination in a phase I clinical trial.
The cloudy thinking caused by some chemotherapies may be due to Interruptions to DNA repair in the brain.
A new approach allows researchers to investigate cells’ mechanical properties in tissue-like environments.
Tumor-promoting signals are elevated in lung tumor cells with high bacterial burdens.
Scientists have assembled a library of immune receptors that direct T cells to target cells with mutations in p53, the most commonly mutated gene in human cancers.
Machine learning model predicts T cells’ tumor response.